Abstract
The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.
| Original language | English |
|---|---|
| Journal | Danish Medical Bulletin (Online) |
| Volume | 58 |
| Issue number | 11 |
| Pages (from-to) | A4331 |
| ISSN | 1603-9629 |
| Publication status | Published - 2011 |
Fingerprint
Dive into the research topics of 'Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS